We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$172M
AUM Growth
+$12.7M
(+8%)
Cap. Flow
+$4.52M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
165
New
41
Increased
29
Reduced
42
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Radware
RDWR
|
+$5.08M |
| 2 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$3.48M |
| 3 |
OneSpan
OSPN
|
+$3.45M |
| 4 |
BOBE
Bob Evans Farms, Inc.
BOBE
|
+$3.34M |
| 5 |
SONC
Sonic Corp
SONC
|
+$3.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$7.17M |
| 2 |
CVSA
Covista Inc
CVSA
|
+$5.33M |
| 3 |
MasTec
MTZ
|
+$4.11M |
| 4 |
HF
HFF Inc.
HF
|
+$4.09M |
| 5 |
SABA
SABA SOFTWARE INC
SABA
|
+$3.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.09% |
| 2 | Healthcare | 16.04% |
| 3 | Consumer Discretionary | 13.67% |
| 4 | Industrials | 12.24% |
| 5 | Financials | 7.14% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, 1492 Capital Management held 165 positions worth $172M, up 8% from $160M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
1492 Capital Management's Q1 2015 filing shows 41 new, 29 increased, 42 reduced and 31 closed positions. Its largest new stake was Radware: 239,040 shares worth $5M. The largest sale was SALIX PHARMACEUTICALS LTD DEL, an estimated $7.17M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 1492 Capital Management's largest Q1 2015 buy was Radware: 239,040 shares worth $5M.
- 1492 Capital Management added most to Axon Enterprise in Q1 2015, an estimated $2.93M increase.
- 1492 Capital Management's biggest Q1 2015 reduction was STAAR Surgical, cutting an estimated $1.95M.
- 1492 Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q1 2015, selling an estimated $7.17M.
- 1492 Capital Management's ten largest holdings make up 33% of its $172M portfolio in Q1 2015.
- 1492 Capital Management opened 41 new positions and closed 31 in Q1 2015.
- 1492 Capital Management's portfolio value rose 8% quarter-over-quarter to $172M.
Based on 1492 Capital Management's 13F filing for Q1 2015, filed 13 May 2015.